A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia

British Journal of Haematology

Volumn 163, Issue 3, 2013, Pages 393-399

  Birgens, Henrik ^a   Frederiksen, Henrik ^b   Hasselbalch, Hans C ^c   Rasmussen, Inge H ^d   Nielsen, Ove J ^e   Kjeldsen, Lars ^e   Larsen, Herdis ^f   Mourits Andersen, Torben ^g   Plesner, Torben ^h   Rønnov Jessen, Dorthe ^f   Vestergaard, Hanne ^h   Klausen, Tobias W ^a   Schöllkopf, Claudia ^c  

^a Mental Health Center Glostrup   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c ROSKILDE HOSPITAL   (Denmark)

^d AALBORG UNIVERSITY HOSPITAL   (Denmark)

^e University of Copenhagen   (Denmark)

^f VIBORG HOSPITAL   (Denmark)

^g University of Esbjerg   (Denmark)

^h LILLEBAELT HOSPITAL   (Denmark)

Author keywords

Antibody therapy; Clinical trials; Immune haemolytic anaemia

Indexed keywords

FOLIC ACID; PREDNISOLONE; RITUXIMAB;

ADULT; AGED; ALLERGIC REACTION; ARTHRALGIA; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BRAIN ISCHEMIA; CLOSTRIDIUM DIFFICILE INFECTION; COMBINATION CHEMOTHERAPY; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG FATALITY; DRUG RESPONSE; DRUG SAFETY; DYSPEPSIA; DYSPNEA; ERYTHROCYTE TRANSFUSION; FATIGUE; FEMALE; FEVER; FOLLOW UP; HEADACHE; HEART FAILURE; HEART PALPITATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPOTENSION; IMMUNOSUPPRESSIVE TREATMENT; INCREASED APPETITE; INSOMNIA; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; NAUSEA; PHASE 3 CLINICAL TRIAL; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE FREE SURVIVAL; RESTLESS LEGS SYNDROME; STEROID THERAPY; TREATMENT DURATION; URINARY TRACT INFECTION; VERTIGO;

ANTIBODY THERAPY; CLINICAL TRIALS; IMMUNE HAEMOLYTIC ANAEMIA;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; DISEASE-FREE SURVIVAL; DYSPEPSIA; DYSPNEA; FATIGUE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PAIN; PNEUMONIA; PREDNISOLONE; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 84885425139     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12541     Document Type: Article

References (25)

1. Arnold, D.M., Heddle, N.M., Carruthers, J., Cook, D.J., Crowther, M.A., Meyer, R.M., Liu, Y., Cook, R.J., McLeod, A., MacEachern, J.A., Mangel, J., Andersen, D., Vickars, L., Tinmouth, A., Schuh, A.C. & Kelton, J.G. (2012) A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia. Blood, 119, 1356-1362.
2. Barcellini, W., Zaja, F., Zaninoni, A., Imperiali, F.G., Battista, M.L., Di Bona, E., Fattizzo, B., Consonni, D., Cortelezzi, A., Fanin, R. & Zanella, A. (2012) Low-dose rituximab in adult patients with idiopathic autoimmune haemolytic anaemia: clinical efficacy and biological studies. Blood, 119, 3691-3697.
3. Berentsen, S., Ulvestad, E., Gjertsen, B.T., Hjorth-Hansen, H., Langholm, R., Knutsen, R., Ghanima, W., Shammas, F.V. & Tjønfjord, G.E. (2004) Rituximab for primary cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients. Blood, 103, 2925-2928.
4. Bussone, G., Ribeiro, E., Dechartres, A., Viallard, J.-F., Bonnotte, B., Fain, O., Godeau, B. & Michel, M. (2009) Efficacy and safety of rituximab in adults' warm antibody autoimmune haemolytic anaemia: retrospective analysis of 27 cases. American Journal of Hematology, 84, 153-157.
5. Chemnitz, J., Draube, A., Diehl, V. & Wolf, J. (2002) Successful treatment of steroid and cyclophosphamide-resistant hemolysis in chronic lymphocytic leukemia with rituximab. American Journal of Hematology, 69, 232-235.
6. Crowther, M., Chan, Y.L.T., Garbett, I.K., Lim, W., Vickers, M.A. & Crowther, M.A. (2011) Evidence-based focused review of the treatment of idiopathic warm immune haemolytic anaemia in adults. Blood, 118, 4036-4040.
7. D'Arena, G., Califano, C., Annunziata, M., Tartarone, A., Capalbo, S., Villani, O., Amendola, G., Pietrantuono, G., Ferrara, F., Pinto, A., Musto, P., D'Arco, A.M. & Cascavilla, N. (2007) Rituximab for warm- type idiopathic autoimmune haemolytic anaemia: a retrospective study of 11 adult patients. European Journal of Haematololy, 79, 53-58.
8. Dierickx, D., Verhoef, G., Van Hoof, A., Mineur, P., Roest, A., Triffet, A., Kentos, A., Pierre, P., Boulet, D., Bries, G., Le, P.-Q., Janssens, A. & Delannoy, A. (2009) Rituximab in auto-immune haemolytic and immune thrombocytopenic purpura: a Belgian retrospective multicentric study. Journal of Internal Medicine, 266, 484-491.
9. Garvey, B. (2008) Rituximab in the treatment of autoimmune haematological disorders. British Journal of Haematology, 141, 149-169.
10. Gupta, N., Kavuru, S., Patel, D., Janson, D., Driscoll, N., Ahmed, S. & Rai, K.R. (2002) Rituximab-based chemotherapy for steroid-refractory autoimmune haemolytic anaemia of chronic lymphocytic leukemia. Leukemia, 16, 2092-2095.
11. Narat, S., Gandla, J., Hoffbrand, A.V., Hughes, R.G. & Mehta, A.B. (2005) Rituximab in the treatment of refractory autoimmune cytopenias in adults. Haematologica, 90, 1273-1274.
12. Perrotta, S., Locatelli, F., La Manna, A., Cennamo, L., De Stefano, P. & Nobili, B. (2002) Anti-CD20 monoclonal antibody (Rituximab) for life-threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosus. British Journal of Haematology, 116, 465-467.
13. Petz, L.D. (2001) Treatment of autoimmune haemolytic anaemias. Current Opinion in Hematology, 8, 411-416.
14. Petz, L.D. & Garratty, G. (2004) Immune Haemolytic Anaemias, 2nd edn. Churchill Livingstone, Philadelphia.
15. Quartier, P., Brethon, B., Philippet, P., Landman-Parker, J., Le Deist, F. & Fischer, A. (2001) Treatment of childhood autoimmune haemolytic with rituximab. The Lancet, 358, 1511-1513.
16. Ramanathan, S., Koutts, J. & Hertzberg, M.S. (2005) Two cases of refractory warm autoimmune haemolytic anaemia treated with rituximab. American Journal of Hematololgy, 78, 123-126.
17. Rao, A., Kelly, M., Musselman, M., Ramadas, J., Wilson, D., Grossman, W. & Shenoy, S. (2008) Safety, efficacy, and immune reconstitution after rituximab therapy in pediatric patients with chronic and refractory hematologic autoimmune cytopenias. Pediatric Blood & Cancer, 50, 822-825.
18. Reff, M.E., Carner, K., Chambers, K.S., Chinn, P.C., Leonard, J.E., Raab, R., Newman, R.A., Hanna, N. & Anderson, D.R. (1994) Depletion of B-cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood, 83, 435-445.
19. Roll, P., Palanichamy, A., Kneitz, C., Dorner, T. & Tony, H.-P. (2006) Regeneration of B cell subsets after transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis. Arthritis and Rheumatism, 54, 2377-2386.
20. Schöllkopf, C., Kjeldsen, L., Bjerrum, O.W., Mourits-Andersen, H.T., Nielsen, J.L., Christensen, B.E., Jensen, B.A., Pedersen, B.B., Taaning, E.B., Klausen, T.W. & Birgens, H. (2006) Rituximab in chronic cold agglutinin disease: a prospective study of 20 patients. Leukemia & Lymphoma, 47, 253-260.
21. Shanafelt, T.D., Madueme, H.L., Wolf, R.C. & Tefferi, A. (2003) Rituximab for Immune Cytopenia in Adults: idiopathic Thrombocytopenic Purpura, Autoimmune Haemolytic Anaemia, and Evans Syndrome. Mayo Clinic Proceeding, 78, 1340-1346.
22. Stasi, R. (2010) Rituximab in Autoimmune Hematologic Diseases: not Just a Matter of B Cells. Seminars in Hematology, 47, 170-179.
23. Zaja, F., Battista, M.L., Pirotta, M.T., Palmieri, S., Montagna, M., Vianelli, N., Marin, L., Cavallin, M., Bocchia, M., Defina, M., Ippoliti, M., Ferrara, K., Patriarca, F., Avanzini, M.A., Regazzi, M., Baccarani, M., Isola, M., Soldano, F. & Fanin, R. (2008) Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura. Haematologica, 93, 930-933.
24. Zaja, F., Baccarani, M., Mazza, P., Bocchia, M., Gugliotta, L., Zaccaria, A., Vianelle, N., Defina, M., Tieghi, A., Amadori, S., Campagna, S., Ferrara, F., Angelucci, E., Usula, E., Cantoni, S., Visani, G., Fornaro, A., Rizzi, R., De Stefano, V., Casulli, F., Battista, M.L., Isola, M., Soldano, F., Gamba, E. & Fanin, R. (2010) Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia. Blood, 115, 2755-2762.
25. Zecca, M., Nobili, B., Ramenghi, U., Perrotta, S., Amendola, G., Rosito, P., Jamkovic, M., Pierani, P., De Stefano, P., Borana, M.R. & Locatelli, F. (2003) Rituximab for the treatment of refractory autoimmune haemolytic anaemia in children. Blood, 101, 3857-3861.